(Q44613104)

4 December 2017

Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function (English)

1 reference

4 December 2017

Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial Function (English)

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Cardiology and cardiovascular medicine

20 March 2024

main subject

endothelium

0 references

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

20 March 2024

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

20 March 2024

1

Sven Wassmann

1 reference

4 December 2017

6

Georg Nickenig

1 reference

4 December 2017

Anna Faul

2

1 reference

4 December 2017

Benno Hennen

3

1 reference

4 December 2017

Bruno Scheller

4

1 reference

4 December 2017

Michael Böhm

5

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14551237

20 March 2024

publication date

9 October 2003

1 reference

4 December 2017

1 reference

4 December 2017

93

1 reference

4 December 2017

9

1 reference

4 December 2017

e98-103

1 reference

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

4 December 2017

2

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

20 March 2024

3

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

20 March 2024

4

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

20 March 2024

5

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Statins do more than just lower cholesterol

20 March 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.

20 March 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Pleiotropic effects of HMG-CoA reductase inhibitors

20 March 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

20 March 2024

10

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

20 March 2024

11

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study)

20 March 2024

13

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

20 March 2024

14

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Atherosclerosis — An Inflammatory Disease

20 March 2024

15

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis

20 March 2024

16

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Cellular and molecular mechanisms of endothelial cell dysfunction

20 March 2024

17

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Interrelationship of Free Oxygen Radicals and Endothelial Dysfunction--Modulation by Statins

20 March 2024

18

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks.

20 March 2024

22

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women

20 March 2024

25

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Effect of exercise on coronary endothelial function in patients with coronary artery disease.

20 March 2024

26

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study

20 March 2024

33

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

20 March 2024

34

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

20 March 2024

36

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells

20 March 2024

37

1 reference

https://api.crossref.org/works/10.1161/01.RES.0000099503.13312.7B

20 March 2024

Identifiers

1 reference

4 December 2017

1 reference